Phase 2 Dose-finding IMU-838 for Ulcerative Colitis

Clinical trial NCT03341962 · TERMINATED

Trial details

NCT number: NCT03341962
Sponsor: Immunic AG
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2018-03-15
Primary completion: 2022-11-16
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.